This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Glaxosmithkline LLC. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: Mariela Colón: Innovator in Prolyl Hydroxylase Inhibitors
Introduction
Mariela Colón is a notable inventor based in Collegeville, PA (US). She has made significant contributions to the field of medicinal chemistry, particularly in the development of prolyl hydroxylase inhibitors. Her work is essential in advancing therapeutic options for various diseases.
Latest Patents
Mariela Colón holds a patent for "Substituted 1,8-naphthyridinecarboxamides for use as prolyl hydroxylase inhibitors." This invention relates to certain bicyclic heteroaromatic N-substituted glycine derivatives, which have potential applications in treating conditions associated with prolyl hydroxylase activity.
Career Highlights
Colón is currently employed at GlaxoSmithKline LLC, where she continues to engage in innovative research. Her expertise in medicinal chemistry has positioned her as a valuable asset in her field.
Collaborations
Mariela has collaborated with her coworker, Duke M Fitch, to further enhance the research and development of her inventions. Their combined efforts contribute to the advancement of new therapeutic strategies.
Conclusion
Mariela Colón's work in developing prolyl hydroxylase inhibitors showcases her innovative spirit and dedication to improving healthcare solutions. Her contributions are paving the way for future advancements in medicinal chemistry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile